Needham & Company raised its price target on Hologic (NASDAQ: HOLX) to $48.00 (from $43.00) while maintaining a Buy rating.Analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Hologic (HOLX) PT Raised to $45 at CowenAugust 1, 2018 7:26 AM Hologic (HOLX) PT Raised to $46 at Evercore ISIAugust 1, 2018 7:17 AM Hologic (HOLX) PT Raised to $47 at BTIGAugust 1, 2018 6:16 AM Hologic (HOLX) CFO Bob McMahon to Leave; Karleen Oberton Named New CFOJuly 31, 2018 5:28 PM Form 10-Q HOLOGIC INC For: Jun 30July 31, 2018 4:16 PM Form 8-K HOLOGIC INC For: Jul 26July 31, 2018 4:08 PM Form 8-K HOLOGIC INC For: Jul 31July 31, 2018 4:06 PM Hologic (HOLX) to Acquire Faxitron Bioptics for Approximately $85 MillionJuly 31, 2018 4:05 PM Hologic (HOLX) Tops Q3 EPS by 2cJuly 31, 2018 4:04 PM Hologic Announces Financial Results for Third Quarter of Fiscal 2018July 31, 2018 4:02 PM